IMUC
EOM Pharmaceutical Holdings, Inc.Company Information
- Company Name
- EOM Pharmaceutical Holdings, Inc.
- CIK
- CIK0000822411
- Category
- Smaller reporting company
- Ticker: Exchange
- IMUC: OTC
- Fiscal Year End
- December 31
- Owner Organization
- Not Available
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- IMUC
SEC filing data through
Insider Sentiment
- Last purchase
- 2015-11-30
- Last sale
- 2013-11-26
- Shares purchased (TTM)
- 98,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2018-09-30
- Institutional shares owned
- 1,930,912
- Shares outstanding
- 41,913,256
- Ownership
- 4.61%
Earnings Market Reaction
- Filing date
- —
- Price on filing date
- —
- 1-month reaction
- —
- 3-month reaction
- —
Balance Sheet
Values in millions ($)| Line item | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 3 | 5 | 7 | 6 | 2 | 5 | 11 | 15 | 12 | 18 | 23 | 24 | ||||||
| Supplies | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 1 | - | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 4 | 5 | 7 | 7 | 4 | 7 | 13 | 17 | 14 | 19 | 25 | 26 | ||||||
| Other Assets Current | 0 | 0 | 0 | 1 | 3 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Insurance Settlements Receivable Current | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Noncurrent | - | - | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | - | ||||||
| Other Assets Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Deposits Assets Noncurrent | - | - | 0 | 0 | 0 | 2 | 2 | 4 | 3 | 4 | 4 | 4 | ||||||
| Deferred Finance Costs Noncurrent Net | - | - | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | - | ||||||
| Assets | 4 | 5 | 7 | 7 | 5 | 11 | 17 | 22 | 19 | 25 | 30 | 31 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 0 | 1 | 2 | 4 | 4 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 0 | 1 | 2 | 7 | 8 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | ||||||
| Employee Related Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | ||||||
| Accrued Liabilities Current | 0 | 0 | 0 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | ||||||
| Long Term Debt | - | - | 0 | 0 | 0 | 7 | 7 | 7 | 5 | 4 | 4 | - | ||||||
| Warrants And Rights Outstanding | - | - | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 1 | 2 | 3 | ||||||
| Liabilities | - | - | 2 | 7 | 8 | 10 | 11 | 11 | 7 | 8 | 8 | - | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital | - | - | 121 | - | - | - | 102 | - | - | - | 96 | - | ||||||
| Stockholders Equity | 3 | 4 | 5 | -1 | -3 | 0 | 6 | 12 | 12 | 17 | 22 | 26 | ||||||
| Additional Paid In Capital Common Stock | 121 | 121 | - | 115 | 103 | 103 | - | 102 | 97 | 96 | - | 96 | ||||||
| Retained Earnings Accumulated Deficit | -118 | -117 | -116 | -116 | -106 | -102 | -96 | -90 | -85 | -80 | -74 | -69 | ||||||
| Liabilities And Stockholders Equity | 4 | 5 | 7 | 7 | 5 | 11 | 17 | 22 | 19 | 25 | 30 | 31 | ||||||
| Preferred Stock Dividend Rate Percentage | - | - | - | 0 | - | - | - | - | - | - | - | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | - | 1 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 50 | 50 | 50 | 50 | 25 | 25 | 50 | 249 | 249 | 249 | 25 | 149 | ||||||
| Common Stock Shares Issued | 42 | 42 | 42 | 24 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | ||||||
| Shares Outstanding | 42 | 42 | 42 | 24 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialEOM Pharmaceutical Holdings, Inc. (IMUC) — SEC Financial Statements & Analysis
EOM Pharmaceutical Holdings, Inc. (IMUC) is a pharmaceutical preparations company, incorporated in DE. EOM Pharmaceutical Holdings, Inc. trades on OTC as: IMUC. EOM Pharmaceutical Holdings, Inc. (IMUC)'s most recent SEC filing is a Form 10-Q for the period ended 2018-06-30, filed with the SEC on 2018-08-13. Based on that filing, On profitability, EOM Pharmaceutical Holdings, Inc. posts an operating margin of -2414.63%, a net margin of 3369.33%, a Return on Equity (ROE) of -3687.49%, a Return on Assets (ROA) of -209.11%, and a Return on Invested Capital (ROIC) of -798.40%. Per share, it reports EPS of $-0.22, free cash flow per share of $-0.26, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -57.19% year-over-year, and EPS growth of -96.37% year-over-year. On the balance sheet, it maintains a current ratio of 9.53x, a quick ratio of 9.53x, working capital of $3.43M, a debt-to-equity ratio of 0.12x, a debt ratio of 0.1, an interest coverage ratio of -38.83x, free cash flow of $-10.93M (TTM), and net debt of $-2.85M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-0.22
- ROE TTM
- -3687.49%
- ROA TTM
- -209.11%
- Debt To Equity
- 0.12x
- Free Cash Flow TTM
- $-10.93M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2018-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is EOM Pharmaceutical Holdings, Inc. in?
EOM Pharmaceutical Holdings, Inc. (IMUC) operates in the Pharmaceutical Preparations industry.
What exchange does IMUC trade on?
EOM Pharmaceutical Holdings, Inc. (IMUC) trades on the OTC.
Where is EOM Pharmaceutical Holdings, Inc. incorporated?
EOM Pharmaceutical Holdings, Inc. is incorporated in DE.
When was EOM Pharmaceutical Holdings, Inc. (IMUC)'s most recent SEC filing?
EOM Pharmaceutical Holdings, Inc. (IMUC)'s most recent SEC filing is a Form 10-Q for the period ended 2018-06-30, filed with the SEC on 2018-08-13.
What is IMUC's EPS (earnings per share)?
EOM Pharmaceutical Holdings, Inc. (IMUC)'s trailing twelve month EPS is $-0.22 as of 2018-06-30.
What is IMUC's ROE (return on equity)?
EOM Pharmaceutical Holdings, Inc. (IMUC)'s trailing twelve month Return on Equity (ROE) is -3687.49% as of 2018-06-30.
What is IMUC's ROA (return on assets)?
EOM Pharmaceutical Holdings, Inc. (IMUC)'s trailing twelve month Return on Assets (ROA) is -209.11% as of 2018-06-30.
What is IMUC's ROIC (return on invested capital)?
EOM Pharmaceutical Holdings, Inc. (IMUC)'s trailing twelve month Return on Invested Capital (ROIC) is -798.40% as of 2017-03-31.